Global Prostate Cancer Diagnostics Market Report 2024

Prostate Cancer Diagnostics Global Market Report 2024 – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma), By Peer Groups (Adult, Pediatric, Geriatrics), By End User (Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Prostate Cancer Diagnostics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Prostate Cancer Diagnostics Market Definition And Segments

Prostate cancer diagnostics refers to the process of determining and verifying the presence of prostate cancer using diagnostic testing and medical evaluations to evaluate the status and severity of the illness and direct treatment choices. It is commonly used to treat prostatic adenocarcinoma, transitional cell carcinomas, and neuroendocrine tumors.

The main products of prostate cancer diagnostics are instruments, reagents and consumables, accessories. Accessories refer to items in the kit that are not typically necessary but can be used with or added to something else to make it more effective, a prostate-specific antigen (PSA) test kit, biopsy needle, and ultrasound gel are used in the diagnosis of prostate cancer. The various test types include preliminary tests and confirmatory tests that diagnose various prostate cancers such as squamous cell cancer, small cell carcinoma, transitional cell cancer, prostatic adenocarcinoma, ductal adenocarcinoma, small cell prostate cancer, acinar adenocarcinoma. These are used by various peer groups such as adult, pediatric, and geriatrics and also performed by various end users such as hospitals, independent diagnostic laboratories, cancer research institutes, others

The prostate cancer diagnostics market covered in this report is segmented –

1) By Products: Instruments, Reagents And Consumables, Accessories

2) By Test Type: Preliminary Tests, Confirmatory Tests

3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma

4) By Peer Groups: Adult, Pediatric, Geriatrics

5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users

The prostate cancer diagnostics market size has grown rapidly in recent years. It will grow from $3.86 billion in 2023 to $4.4 billion in 2024 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to the increasing aging population, advancements in medical imaging, rising awareness and screening programs, public health initiatives, and improved biopsy techniques.

The prostate cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.11 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to the integration of artificial intelligence (AI), growth of telemedicine in cancer screening, advancements in genomic profiling, patient-centric approaches, and multiparametric MRI for diagnosis. Major trends in the forecast period include liquid biopsy technologies, technological advances in biomarker detection, clinical research and development, digital pathology integration, emergence of multiplex biomarker assays.

Global Surge In Prostate Cancer Cases Drives Expansion Of Prostate Cancer Diagnostics Market

The increasing prevalence of prostate cancer is expected to propel the growth of the prostate cancer diagnostics market going forward. Prostate cancer is a condition in which cancer arises in the prostate gland, a component of the male and female reproductive systems. Prostate cancer diagnostics helps patients to diagnose the disease early with various tests, including prostate-specific antigen (PSA) testing and sophisticated imaging techniques. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based non-profit organization dedicated to eliminating cancer, approximately 288,300 new cases of prostate cancer and 34,700 deaths attributed to prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is expected to propel the growth of the prostate cancer diagnostics market.

A Surge In Spending Accelerates Prostate Cancer Diagnosis Market

The increase in healthcare spending is driving the growth of the prostate cancer diagnosis market. Healthcare spending refers to the total amount of financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending allocates and uses resources for prostate cancer diagnosis to facilitate early detection, accurate staging, and timely intervention, aiming to improve patient outcomes, survival rates, and the overall quality of care for individuals affected by prostate cancer. For instance, in March 2023, according to the American Medical Association (AMA), a US-based professional association and lobbying group of physicians and medical students, health spending in the United States increased by 2.7% in 2021 to $4.3 trillion, or $12,914 per capita. Therefore, an increase in healthcare spending is driving the growth of the prostate cancer diagnosis market going forward.

Major companies operating in the prostate cancer diagnostics market report are F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., GRAIL Inc., Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd., Exosome Diagnostics Inc., Eurolyser Diagnostica GmbH, Dana-Farber Cancer Institute, Vyant Bio Inc., Cellanyx Diagnostics Inc., A3P Biomedical AB

Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market

Technological innovations are a key trend gaining popularity in the prostate cancer diagnostics market. Major companies operating in prostate cancer diagnostics are introducing innovative AI-powered prostate cancer diagnosis tools to sustain their position in the market. For instance, in March 2023, Qritive, a Singapore-based company that develops diagnostic tools, launched QAi Prostate, an advanced AI-powered prostate cancer diagnosis tool for pathologists. These tools include advanced machine learning algorithms that identify the prostatic adenocarcinoma region and analyze whole slide images of prostate core needle biopsies. This tool helps pathologists to perform accurate diagnoses quickly and reduces the time taken for the treatment.

Lantheus Holdings Inc. And Novartis AG Forge Strategic Partnership To Propel Precision Medicine In Prostate Cancer Diagnostics

Major companies operating in the prostate cancer diagnostics market are adopting a strategic partnership approach to advance cancer precision medicine by enabling partners to use PYLARIFY in prostate cancer therapeutic trials. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in March 2022, Lantheus Holdings Inc., a US-based diagnostic and imaging products company, partnered with Novartis AG, a Switzerland-based pharmaceutical company. With this partnership, they aim to use Lantheus' prostate-specific membrane antigen (PSMA) imaging agent, PYLARIFY (piflufolastat F18), in clinical trials for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to select patients with prostate cancer for enhanced diagnosis.

MDxhealth Sa Strengthens Prostate Diagnostics Portfolio Through Strategic Acquisition Of Exact Sciences Corporation

In August 2022, MDxHealth SA, a US-based commercial-stage precision diagnostics company, acquired Exact Sciences Corporation for an undisclosed amount. With this acquisition, MDxHealth enhanced its leadership in the precision diagnostics urology market and expanded its prostate diagnostics business with the Oncotype DX GPS (Genomic Prostate Score) test within the urology community. Exact Sciences Corporation is a US-based cancer screening and diagnostic tests company focused on cancer products, including prostate pipelines software to support patients before and throughout their cancer diagnosis and treatment.

North America was the largest region in the prostate cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prostate cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prostate cancer diagnostics market consists of revenues earned by entities by providing transrectal ultrasound, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The prostate cancer diagnostics market also includes sales of products such as tumor biopsies, and test kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The prostate cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides prostate cancer diagnostics market statistics, including prostate cancer diagnostics industry global market size, regional shares, competitors with a prostate cancer diagnostics market share, detailed prostate cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the prostate cancer diagnostics industry. This prostate cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Prostate Cancer Diagnostics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $4.4 billion
Revenue Forecast In 2033 $7.11 billion
Growth Rate CAGR of 12.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Products: Instruments, Reagents And Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Pediatric, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F. Hoffman-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Siemens Healthineers AG; Becton Dickinson and Company; Agilent Technologies Inc.; Hologic Inc; Biomerieux SA; Beckman Coulter Inc.; Qiagen N.V.; EXACT Sciences Corporation; Diasorin S.P.A.; OPKO Health Inc.; Myriad Genetics Inc.; Cepheid Inc; NeoGenomics Laboratories Inc.; Guardant Health Inc; GRAIL Inc; Fujirebio Diagnostics Inc.; Ambry Genetics Corporation; MDxHealth SA; Biocept Inc.; Blue Earth Therapeutics Ltd; Exosome Diagnostics Inc.; Eurolyser Diagnostica GmbH; Dana-Farber Cancer Institute; Vyant Bio Inc.; Cellanyx Diagnostics Inc.; A3P Biomedical AB
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Prostate Cancer Diagnostics Market Characteristics

    3. Prostate Cancer Diagnostics Market Trends And Strategies

    4. Prostate Cancer Diagnostics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Prostate Cancer Diagnostics Market Size and Growth

    5.1. Global Prostate Cancer Diagnostics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Prostate Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Prostate Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Prostate Cancer Diagnostics Market Segmentation

    6.1. Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Instruments

    Reagents And Consumables

    Accessories

    6.2. Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Preliminary Tests

    Confirmatory Tests

    6.3. Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Squamous Cell Cancer

    Small Cell Carcinoma

    Transitional Cell Cancer

    Prostatic Adenocarcinoma

    Ductal Adenocarcinoma

    Small Cell Prostate Cancer

    Acinar Adenocarcinoma

    6.4. Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Adult

    Pediatric

    Geriatrics

    6.5. Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Independent Diagnostic Laboratories

    Cancer Research Institutes

    Other End-Users

    7. Prostate Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Prostate Cancer Diagnostics Market

    8.1. Asia-Pacific Prostate Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Prostate Cancer Diagnostics Market

    9.1. China Prostate Cancer Diagnostics Market Overview

    9.2. China Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Prostate Cancer Diagnostics Market

    10.1. India Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Prostate Cancer Diagnostics Market

    11.1. Japan Prostate Cancer Diagnostics Market Overview

    11.2. Japan Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Prostate Cancer Diagnostics Market

    12.1. Australia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Prostate Cancer Diagnostics Market

    13.1. Indonesia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Prostate Cancer Diagnostics Market

    14.1. South Korea Prostate Cancer Diagnostics Market Overview

    14.2. South Korea Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Prostate Cancer Diagnostics Market

    15.1. Western Europe Prostate Cancer Diagnostics Market Overview

    15.2. Western Europe Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Prostate Cancer Diagnostics Market

    16.1. UK Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Prostate Cancer Diagnostics Market

    17.1. Germany Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Prostate Cancer Diagnostics Market

    18.5. France Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Prostate Cancer Diagnostics Market

    19.9. Italy Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Prostate Cancer Diagnostics Market

    20.13. Spain Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Prostate Cancer Diagnostics Market

    21.1. Eastern Europe Prostate Cancer Diagnostics Market Overview

    21.2. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Prostate Cancer Diagnostics Market

    22.1. Russia Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Prostate Cancer Diagnostics Market

    23.1. North America Prostate Cancer Diagnostics Market Overview

    23.2. North America Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Prostate Cancer Diagnostics Market

    24.1. USA Prostate Cancer Diagnostics Market Overview

    24.2. USA Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Prostate Cancer Diagnostics Market

    25.1. Canada Prostate Cancer Diagnostics Market Overview

    25.2. Canada Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Prostate Cancer Diagnostics Market

    26.1. South America Prostate Cancer Diagnostics Market Overview

    26.2. South America Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Prostate Cancer Diagnostics Market

    27.1. Brazil Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Prostate Cancer Diagnostics Market

    28.1. Middle East Prostate Cancer Diagnostics Market Overview

    28.2. Middle East Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Prostate Cancer Diagnostics Market

    29.1. Africa Prostate Cancer Diagnostics Market Overview

    29.2. Africa Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Prostate Cancer Diagnostics Market Competitive Landscape And Company Profiles

    30.1. Prostate Cancer Diagnostics Market Competitive Landscape

    30.2. Prostate Cancer Diagnostics Market Company Profiles

    30.2.1. F. Hoffman-La Roche AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bayer AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Thermo Fisher Scientific Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Abbott Laboratories Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Siemens Healthineers AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Prostate Cancer Diagnostics Market Other Major And Innovative Companies

    31.1. Becton Dickinson and Company

    31.2. Agilent Technologies Inc.

    31.3. Hologic Inc

    31.4. Biomerieux SA

    31.5. Beckman Coulter Inc.

    31.6. Qiagen N.V.

    31.7. EXACT Sciences Corporation

    31.8. Diasorin S.P.A.

    31.9. OPKO Health Inc.

    31.10. Myriad Genetics Inc.

    31.11. Cepheid Inc

    31.12. NeoGenomics Laboratories Inc.

    31.13. Guardant Health Inc

    31.14. GRAIL Inc

    31.15. Fujirebio Diagnostics Inc.

    32. Global Prostate Cancer Diagnostics Market Competitive Benchmarking

    33. Global Prostate Cancer Diagnostics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Prostate Cancer Diagnostics Market

    35. Prostate Cancer Diagnostics Market Future Outlook and Potential Analysis

    35.1 Prostate Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Prostate Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Prostate Cancer Diagnostics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: F. Hoffman-La Roche AG Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: Abbott Laboratories Inc. Financial Performance
  • Table 80: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Prostate Cancer Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Prostate Cancer Diagnostics Market, Segmentation By Prostate Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Prostate Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Prostate Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Prostate Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Prostate Cancer Diagnostics Market, Segmentation By Peer Groups, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Prostate Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: F. Hoffman-La Roche AG Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: Abbott Laboratories Inc. Financial Performance
  • Figure 80: Siemens Healthineers AG Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Semiconductor Machinery Global Market Report 2024 – By Type (Front-End Equipment, Back-End Equipment, Fab Facility Equipment), By Product (Memory, Foundry, Logic, MPU, Discrete, Analog, MEMS, Other Products), By Supply Chain Participant (OSAT Companies, IDM Firms, Foundries), By Application (Integrated Circuit, Discrete Device, Optoelectronic Device, Sensors) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Machinery Global Market Report 2024 – By Type (Automatic, Semi-Automatic), By Capacity (Small, Medium, Large), By Application (Automotive, Precision Engineering, Transport, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Agriculture, Construction, And Mining Machinery Global Market Report 2024 – By Type (Construction Machinery, Agricultural Implement, Mining And Oil And Gas Field Machinery), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity (Small, Medium, Large) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Industrial Machinery Global Market Report 2024 – By Type (Woodworking And Paper Machinery, Printing Machinery And Equipment, Semiconductor Machinery, Food Product Machinery, Other Industrial Machinery), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity (Small, Medium, Large) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Metalworking Machinery Global Market Report 2024 – By Type (Special Die And Tool, Die Set, Jig, And Fixture, Machine Tool, Industrial Mold, Rolling Mill And Other Metalworking Machinery, Cutting Tool And Machine Tool Accessory), By Capacity (Small, Medium, Large), By Application (Automotive, Manufacturing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Fertilizing Machinery Global Market Report 2024 – By Product Type (Fertilizer Dryers, Fertilizer Screening Machines, Fertilizer Crushers, Fertilizer Granulators, Fertilizer Mixers), By Disc Type (Single Disc Fertilizer Spreaders, Double Disc Fertilizer Spreaders), By Application (Agriculture, Forestry, Greenbelt, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Farm Machinery And Equipment Global Market Report 2024 – By Type (Cultivator, Rotator, Chisel Plow, Harvester, Roller, Field Sprayer And Spreader, Irrigation System, Livestock equipment, Tractors, Other Types), By Capacity (Small, Medium, Large), By Operation (Manual, Semi-Autonomous, Fully-Autonomous), By Application (Spraying, Water Supply And Conservation, Cultivation, Harvesting, Seeding, Weeding, Livestock Farming, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Commercial And Service Industry Machinery Global Market Report 2024 – By Type (Commercial And Service Industry Machinery, Photographic And Photocopying Equipment, Optical Instrument And Lens), By Operation (Autonomous, Semi-Autonomous, Manual), By Capacity ( Small, Medium, Large) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the prostate cancer diagnostics market?

Prostate cancer diagnostics refers to the process of determining and verifying the presence of prostate cancer using diagnostic testing and medical evaluations with the purpose of evaluating the status and severity of the illness and directing treatment choices. It is commonly used to treat prostatic adenocarcinoma, transitional cell carcinomas, and neuroendocrine tumors. For further insights on the prostate cancer diagnostics market, request a sample here

How will the prostate cancer diagnostics market drivers and restraints affect the prostate cancer diagnostics market dynamics? What forces will shape the prostate cancer diagnostics industry going forward?

The prostate cancer diagnostics market major growth driver - Global Surge In Prostate Cancer Cases Drives Expansion Of Prostate Cancer Diagnostics Market. For further insights on the prostate cancer diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the prostate cancer diagnostics market?

The prostate cancer diagnostics market size has grown rapidly in recent years. It will grow from $3.86 billion in 2023 to $4.4 billion in 2024 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to increasing aging population, advancements in medical imaging, rising awareness and screening programs, public health initiatives, improved biopsy techniques. The prostate cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.11 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to integration of artificial intelligence (ai), growth of telemedicine in cancer screening, advancements in genomic profiling, patient-centric approaches, multiparametric mri for diagnosis. Major trends in the forecast period include liquid biopsy technologies, technological advances in biomarker detection, clinical research and development, digital pathology integration, emergence of multiplex biomarker assays. For further insights on the prostate cancer diagnostics market, request a sample here

How is the prostate cancer diagnostics market segmented?

The prostate cancer diagnostics market is segmented
1) By Products: Instruments, Reagents And Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Pediatric, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-UsersFor further insights on the prostate cancer diagnostics market, request a sample here

Which region has the largest share of the prostate cancer diagnostics market? What are the other regions covered in the report?

North America was the largest region in the prostate cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the prostate cancer diagnostics market, request a sample here.

Who are the major players in the prostate cancer diagnostics market?

Major companies operating in the prostate cancer diagnostics market report are F. Hoffman-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc, Biomerieux SA, Beckman Coulter Inc., Qiagen N.V., EXACT Sciences Corporation, Diasorin S.P.A., OPKO Health Inc., Myriad Genetics Inc., Cepheid Inc, NeoGenomics Laboratories Inc., Guardant Health Inc, GRAIL Inc, Fujirebio Diagnostics Inc., Ambry Genetics Corporation, MDxHealth SA, Biocept Inc., Blue Earth Therapeutics Ltd, Exosome Diagnostics Inc., Eurolyser Diagnostica GmbH, Dana-Farber Cancer Institute, Vyant Bio Inc., Cellanyx Diagnostics Inc., A3P Biomedical AB For further insights on the prostate cancer diagnostics market, request a sample here.

What are the key trends in the prostate cancer diagnostics market?

Major trend in the prostate cancer diagnostics market - Innovative Technological Advancements Propel Prostate Cancer Diagnostics Market. For further insights on the prostate cancer diagnostics market, request a sample here.

What are the major opportunities in the prostate cancer diagnostics market? What are the strategies for the prostate cancer diagnostics market?

For detailed insights on the major opportunities and strategies in the prostate cancer diagnostics market, request a sample here.

How does the prostate cancer diagnostics market relate to the overall economy and other similar markets?

For detailed insights on prostate cancer diagnostics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the prostate cancer diagnostics industry?

For detailed insights on the mergers and acquisitions in the prostate cancer diagnostics industry, request a sample here.

What are the key dynamics influencing the prostate cancer diagnostics market growth? SWOT analysis of the prostate cancer diagnostics market.

For detailed insights on the key dynamics influencing the prostate cancer diagnostics market growth and SWOT analysis of the prostate cancer diagnostics industry, request a sample here.